| Pharmacotherapies Approved for Treatment of AUD in the United States |
| Acamprosate |
| Disulfiram |
| Naltrexone (oral) |
| Naltrexone (extended-release injectable) |
| Other Pharmacotherapies Approved for Treatment of AUD in the European Union |
| Gamma-hydroxybutyrate (GHB) |
| Nalmefene |
| Medications Under Investigation for Treatment of Alcohol Dependence |
| Aripiprazole |
| Baclofen |
| Buproprion |
| Gabapentin |
| Kudzu (isoflavone) |
| Memantine |
| Metadoxine |
| Olanzapine |
| Ondansetron |
| Prazosin (alpha-1 antagonist) |
| Quetiapine |
| Rimonabant (CB1 receptor antagonist) |
| SSRIs |
| Topiramate |
| Varenicline |
| Zonisamide |
| CB1, cannabinoid 1; SSRI, selective serotonin reuptake inhibitor. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.